Fulgent Genetics, Inc. (FLGT)

USD 18.74

(-3.6%)

Total Debt Summary of Fulgent Genetics, Inc.

  • Fulgent Genetics, Inc.'s latest annual total debt in 2023 was 14.9 Million USD , down -27.77% from previous year.
  • Fulgent Genetics, Inc.'s latest quarterly total debt in 2024 Q1 was 12.93 Million USD , down -13.21% from previous quarter.
  • Fulgent Genetics, Inc. reported annual total debt of 20.63 Million USD in 2022, down -3.04% from previous year.
  • Fulgent Genetics, Inc. reported annual total debt of 21.28 Million USD in 2021, up 34.25% from previous year.
  • Fulgent Genetics, Inc. reported quarterly total debt of 13.37 Million USD for 2024 Q2, up 3.38% from previous quarter.
  • Fulgent Genetics, Inc. reported quarterly total debt of 4.56 Million USD for 2023 Q2, down -77.87% from previous quarter.

Annual Total Debt Chart of Fulgent Genetics, Inc. (2023 - 2001)

Historical Annual Total Debt of Fulgent Genetics, Inc. (2023 - 2001)

Year Total Debt Total Debt Growth
2023 14.9 Million USD -27.77%
2022 20.63 Million USD -3.04%
2021 21.28 Million USD 34.25%
2020 15.85 Million USD 492.45%
2019 2.67 Million USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2001 - USD 0.0%

Peer Total Debt Comparison of Fulgent Genetics, Inc.

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD 83.05%
Prenetics Global Limited 2.36 Million USD -529.15%
Star Equity Holdings, Inc. 3.6 Million USD -313.051%
CareDx, Inc 34.22 Million USD 56.439%
Exact Sciences Corporation 2.55 Billion USD 99.416%
Exagen Inc. 23.72 Million USD 37.157%
Inotiv, Inc. 417.64 Million USD 96.431%
Guardant Health, Inc. 1.35 Billion USD 98.899%
Biodesix, Inc. 60.69 Million USD 75.438%
BioNexus Gene Lab Corp. 133.39 Thousand USD -11075.082%
Precipio, Inc. 1.11 Million USD -1235.753%
iSpecimen Inc. 196.24 Thousand USD -7496.156%
Natera, Inc. 441.99 Million USD 96.627%
Aspira Women's Health Inc. 2.26 Million USD -557.855%
Standard BioTools Inc. 98.21 Million USD 84.821%
23andMe Holding Co. 76.51 Million USD 80.518%
Castle Biosciences, Inc. 15.31 Million USD 2.632%
Personalis, Inc. 48.96 Million USD 69.554%
Aclaris Therapeutics, Inc. 426 Thousand USD -3399.296%
Applied DNA Sciences, Inc. 1.23 Million USD -1104.353%
OpGen, Inc. 13.04 Million USD -14.285%
T2 Biosystems, Inc. 49.49 Million USD 69.884%
Myriad Genetics, Inc. 145 Million USD 89.719%
ICON Public Limited Company 3.93 Billion USD 99.621%
NeoGenomics, Inc. 611.67 Million USD 97.563%
Star Equity Holdings, Inc. 3.6 Million USD -313.051%
IDEXX Laboratories, Inc. 947.88 Million USD 98.427%
RadNet, Inc. 1.49 Billion USD 99.0%
MDxHealth SA 41.26 Million USD 63.875%
Psychemedics Corporation 2.29 Million USD -548.695%
Illumina, Inc. 2.26 Billion USD 99.341%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 94.06 Million USD 84.153%
DarioHealth Corp. 29.54 Million USD 49.538%
Sera Prognostics, Inc. 1.85 Million USD -702.314%
ENDRA Life Sciences Inc. 394.4 Thousand USD -3679.637%
OPKO Health, Inc. 326.56 Million USD 95.435%
Medpace Holdings, Inc. 142.12 Million USD 89.511%
Neogen Corporation 906.23 Million USD 98.355%
Intelligent Bio Solutions Inc. 871.44 Thousand USD -1610.617%
Prenetics Global Limited 2.36 Million USD -529.15%
Mainz Biomed B.V. 7.42 Million USD -100.882%
bioAffinity Technologies, Inc. 1.57 Million USD -844.294%
Trinity Biotech plc 67.42 Million USD 77.892%
Neuronetics, Inc. 62.47 Million USD 76.139%
Sotera Health Company 2.32 Billion USD 99.359%
bioAffinity Technologies, Inc. 1.57 Million USD -844.294%